Wall Street analysts expect Veeva Systems (NYSE:VEEV) to report earnings of $0.30 per share for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have issued estimates for Veeva Systems’ earnings, with the highest EPS estimate coming in at $0.31 and the lowest estimate coming in at $0.30. Veeva Systems posted earnings of $0.22 per share in the same quarter last year, which indicates a positive year-over-year growth rate of 36.4%. The business is scheduled to issue its next quarterly earnings results on Thursday, May 24th.
According to Zacks, analysts expect that Veeva Systems will report full-year earnings of $1.32 per share for the current financial year, with EPS estimates ranging from $1.30 to $1.33. For the next year, analysts anticipate that the company will post earnings of $1.54 per share, with EPS estimates ranging from $1.48 to $1.60. Zacks Investment Research’s EPS averages are a mean average based on a survey of analysts that that provide coverage for Veeva Systems.
Veeva Systems (NYSE:VEEV) last released its quarterly earnings results on Tuesday, February 27th. The technology company reported $0.17 earnings per share for the quarter, topping analysts’ consensus estimates of $0.15 by $0.02. The business had revenue of $184.92 million during the quarter, compared to analysts’ expectations of $180.13 million. Veeva Systems had a return on equity of 11.89% and a net margin of 20.71%.
In other Veeva Systems news, CFO Timothy S. Cabral sold 40,000 shares of the stock in a transaction dated Wednesday, March 7th. The stock was sold at an average price of $77.01, for a total value of $3,080,400.00. Following the sale, the chief financial officer now owns 30,000 shares of the company’s stock, valued at approximately $2,310,300. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Paul J. Sekhri sold 1,108 shares of the stock in a transaction dated Friday, March 23rd. The shares were sold at an average price of $75.46, for a total value of $83,609.68. Following the completion of the sale, the director now directly owns 13,046 shares in the company, valued at approximately $984,451.16. The disclosure for this sale can be found here. Insiders sold a total of 184,831 shares of company stock worth $13,440,162 in the last ninety days. 19.17% of the stock is owned by corporate insiders.
A number of hedge funds have recently bought and sold shares of the business. Cambridge Investment Research Advisors Inc. raised its position in Veeva Systems by 54.1% in the 4th quarter. Cambridge Investment Research Advisors Inc. now owns 38,760 shares of the technology company’s stock valued at $2,143,000 after purchasing an additional 13,605 shares in the last quarter. Xact Kapitalforvaltning AB raised its position in Veeva Systems by 7.7% in the 4th quarter. Xact Kapitalforvaltning AB now owns 18,061 shares of the technology company’s stock valued at $998,000 after purchasing an additional 1,296 shares in the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp raised its position in Veeva Systems by 19.5% in the 4th quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 187,114 shares of the technology company’s stock valued at $10,344,000 after purchasing an additional 30,535 shares in the last quarter. Westover Capital Advisors LLC acquired a new stake in shares of Veeva Systems during the 4th quarter worth about $237,000. Finally, Sterling Capital Management LLC raised its position in shares of Veeva Systems by 6.4% during the 4th quarter. Sterling Capital Management LLC now owns 88,859 shares of the technology company’s stock worth $4,912,000 after acquiring an additional 5,324 shares in the last quarter. 73.09% of the stock is currently owned by institutional investors.
NYSE VEEV opened at $73.28 on Friday. The firm has a market cap of $10,214.86, a PE ratio of 79.65, a price-to-earnings-growth ratio of 4.35 and a beta of 1.39. Veeva Systems has a twelve month low of $50.09 and a twelve month high of $78.28.
Veeva Systems Company Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, and internationally. The company offers Veeva Commercial Cloud, a suite of multichannel customer relationship management applications, which allow pharmaceutical and biotechnology companies to target and support sales and marketing to physicians, other healthcare professionals, and healthcare organizations through various touch points, including in-person, email, and online; and Veeva Vault, a cloud-based enterprise content management platform and suite of applications for managing commercial functions, including medical, sales, and marketing, as well as research and development functions, such as clinical, regulatory, and quality.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.